With new technologies, concerns about gene patent claims regarding isolated DNA are becoming less relevant, but broad method claims could be more problematic

Dobson, Allison W

Evans, James P

PubMed

Carolina Digital Repository

Gene patents in the US - focusing on what really matters

A: Prometheus Patents Struck Down 9-0: Mayo Collaborative Services v.

AM: Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation,

Associated Press: High court throws out human gene patents.

Court of Appeals for the Federal Circuit:

Court of Appeals for the Federal Circuit: Association for Molecular Pathology et al. v. USTPO et al. Fed Cir

Court of Appeals for the Federal Circuit: Classen Immunotherapies,

Court of Appeals for the Federal Circuit: in re Kubin. Fed Cir

Court of Appeals for the Federal Circuit: Prometheus v.

Debunking the myth that whole-genome sequencing infringes thousands of gene patents.

Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.

House of Representatives Committee on the Judiciary: America Invents Act of

Is there still a place for gene patents in Australia? Implications of recent United States and European case law.

Killing Industry: The Supreme Court Blows Mayo v.

Myriad retains BRCA gene patents in latest legal ruling. phg foundation, 5

of the United States: Syllabus: Bilski v. Kappos.

of the United States. Syllabus: Prometheus v.

Patent and Trademark Office: 35 U.S.C. 101 Inventions Patentable. In:

Patent and Trademark Office: 35 U.S.C. 103 Conditions for patentability; non-obvious subject matter.

Patent and Trademark Office: The Patent Cooperation Treaty (PCT).

Puzzled by Prometheus.

https://cdr.lib.unc.edu/downloads/pr76f9609

Gene patents in the US - focusing on what really matters

Abstract

Similar works

Full text

Available Versions

Carolina Digital Repository